Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lesogaberan (AZD3355) for TLESRs in GERD Patients
NCT00743444Phase 2Completed
- Sponsor
- AstraZeneca
- Start
- Feb 2007
- Primary completion
- Feb 2008
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of lesogaberan in gastroesophageal reflux disease (GERD), sponsored by AstraZeneca. Started Feb 2007; status: completed.
02
Drugs
lesogaberan
03
Conditions
gastroesophageal reflux disease (GERD)
Beyond the preview
Go deeper on NCT00743444.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00743444.